de Torres JA - Search Results

1

[The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].

Morote Robles J, Lorente JA, Reig C, López Pacios MA, de Torres JA, Soler Roselló A. Morote Robles J, et al. Among authors: de torres ja. Actas Urol Esp. 1994 May;18(5):559-61. Actas Urol Esp. 1994. PMID: 7521563 Spanish.

2

[Clinical course of hormone refractory cancer of the prostate].

Morote J, Vila J, López-Pacios MA, De Torres JA, Soler-Roselló A. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1992 Oct;16(9):722-5. Actas Urol Esp. 1992. PMID: 1283286 Spanish.

3

[Can we do without bone gammagraphy in the staging of prostatic cancer?].

Morote J, Olona M, Villa J, Reig C, López MA, de Torres JA, Soler A. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1992 Jun;16(6):487-9; discussion 489-90. Actas Urol Esp. 1992. PMID: 1509919 Spanish.

4

[Treatment of hormone-refractory prostate cancer with estramustine phosphate].

Morote J, López-Pacios MA, Ahmad A, Vila J, de Torres JA. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1991 Sep-Oct;15(5):421-4. Actas Urol Esp. 1991. PMID: 1725472 Clinical Trial. Spanish.

5

[Behavior of prostate-specific antigen (PSA) in prostate tissue: correlation with prostatic acid phosphatase (PAP)].

Morote Robles J, Segura RM, De Torres JA, Soler Roselló A. Morote Robles J, et al. Among authors: de torres ja. Actas Urol Esp. 1987 Mar-Apr;11(2):180-3. Actas Urol Esp. 1987. PMID: 2441576 Spanish. No abstract available.

6

Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.

Morote J, Ruibal A, Palou J, de Torres JA, Soler-Roselló A. Morote J, et al. Among authors: de torres ja. Int J Biol Markers. 1988 Jan-Mar;3(1):23-8. doi: 10.1177/172460088800300105. Int J Biol Markers. 1988. PMID: 2470838

7

[Prostate-specific antigen as an evaluation method in the treatment of hormone-refractory cancer of the prostate].

Morote J, Lorente JA, Vallejo C, Encabo G, López-Pacios MA, De Torres JA, Soler Rosello A. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1994 Jun;18(6):656-9. Actas Urol Esp. 1994. PMID: 7524278 Clinical Trial. Spanish.

8

[The concept of biologic progression in metastatic cancer of the prostate hormonally treated].

Morote J, Lorente JA, Vallejo C, Encabo G, López-Pacios MA, De Torres JA, Soler Roselló A. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1994 Jun;18(6):666-9. Actas Urol Esp. 1994. PMID: 7524279 Spanish.

9

[Final results of complete hormone blockade versus monotherapy in prostatic metastatic cancer. PSA implications].

Morote J, Vallejo C, Lorente JA, Encabo G, López Pacios MA, de Torres JA, Soler Roselló A. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1995 Sep;19(8):604-10. Actas Urol Esp. 1995. PMID: 8669327 Clinical Trial. Spanish.

10

[Effect of finasteride on the percentage of free PSA: implications in the early diagnosis of prostatic cancer].

Morote J, Lorente JA, Raventós CX, López MA, Encabo G, De Torres I, López M, De Torres JA. Morote J, et al. Among authors: de torres ja. Actas Urol Esp. 1998 Nov-Dec;22(10):835-9. Actas Urol Esp. 1998. PMID: 9949572 Clinical Trial. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters